A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects
- Ryan P. Cantwell Chater
- Julian Peiser-Oliver
- Tanmay K. Pati
- Ada S. Quinn
- Irina Lotsaris
- Zachary J. Frangos
- Kristen E. Anderson
- Anna E. Tischer
- Billy J. Williams-Noonan
- Karin R. Aubrey
- Megan L. O’Mara
- Michael Michaelides
- Sarasa A. Mohammadi
- Christopher L. Cioffi
- Robert J. Vandenberg
- Azadeh Shahsavar
2026-02-16